THE BRAIN-DAMAGED VICTIMS OF SWINE FLU VACCINE – WINS 63 MILLION DOLLAR LAWSUIT

http://vaccineliberationarmy.com/2015/04/17/brain-damaged-victims-of-swine-flu-vaccine-win-63-million-lawsuit/

Brain-Damaged Victims of Swine Flu Vaccine Win $63 Million Lawsuit

glaxosmithkline_raises_853_million_by_halving_stake_in_south_african_drugmaker

GlaxoSmithKline (GSK) is in the news again making headlines after having to settle another major lawsuit bringing the latest total to over $9.1 billion since 2003.

This time, it is due to GSK’s product Pandemrix, which was the swine flu vaccine forced upon the public during the pandemic of 2009 (which is argued by some to have been fake). As the victims are being compensated in the U.K., the same neurological mechanisms that damaged the children in the lawsuit are still potentially at work in the confirmed excitotoxicity that takes place after many vaccine injections.  Read more…

OTHER LAWSUITS

Glaxo Settles Lawsuit for $750 Million for Tainted Drugs

Uploaded on Oct 26, 2010

GlaxoSmithKline (NYSE:GSK) agreed to pay $750 million to settle criminal and civil complaints that the firm knowingly sold 20 drugs that carried questionable safety made at a large plant in Puerto Rico that was contaminated for years.

The settlement is just one of many charges against drug makers recently, that have resulted in million dollar fines.

Among the drugs was contaminated baby ointment and an ineffective antidepressant.

On September 15, 2010, GlaxoSmithKline (NYSE:GSK) was downgraded to Hold from Buy at Jefferies. The stock is trading at $40.16 which is 0.29% higher than the downgrade price of $40.05.

GlaxoSmithKline Settles Avandia Lawsuit for $460 Million, Analysts See It As A Win (GSK)

Uploaded on Jul 14, 2010

July 14, 2010– GlaxoSmithKline (NYSE:GSK) agreed to pay approximately $460 million in order settle the majority of lawsuits that alleged its Avandia diabetes drug can cause heart attacks and strokes.

The average settlement, $46,000, is considered to be a win for the firm among most analysts.

Many analysts expected a worst case scenario to have been approximately $500,000 per case.

Shares of GlaxoSmithKline are trading 0.9% higher to $36.04.

 

This entry was posted in * COURT CASE INFO, * FREEDOM FIGHTERS, * FROM THE FIRST ORDER, * HUMAN LIFE INTERESTS, * MILITARY FORCE UNITS, - CRIMES Against Humanity, - INSANE DICTATOR MOVES, - WARS - ON HUMANITY, - WARS EVIL COMPANIES, - WARS ON DISEASES, DEATHS OF HUMANS, FOOD - TO - AVOID, HEALTH CARE CRIMES, HUMAN ODD DISEASES, ILLUMINATI DECEPTIONS, ILLUMINATI EVIL Devices, LAW ENFORCEMENT, LAWSUITS - CHARGED, MILITARY - WAR MOVES, MILITARY RESOURCES, MILITARY Secret Weapon, PHARMACEUTICAL FRAUD, UNJUST FRAUD CRIMES, UNJUST THEFT CRIMES, URGENT MESSAGES, VACCINATIONS ♠ KILL, WHAT IS HAPPENING ?. Bookmark the permalink.

Leave a comment